High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2{degrees}P - TIMI 50 Trial [Lipids, Lipoproteins, and Cardiovascular Risk Factors]

CONCLUSIONS:
In stable patients with established atherosclerosis, hs-TnI concentrations effectively stratified the risk of new or recurrent cardiovascular (CV) events, in particular CV death and MI. High-risk patients with prior MI identified by increased hs-TnI had a substantial absolute improvement in net clinical outcome with vorapaxar.

Source: Clinical Chemistry - December 29, 2016 Category: Chemistry Authors: Eisen, A., Bonaca, M. P., Jarolim, P., Scirica, B. M., White, H. D., Tendera, M., Dellborg, M., Nicolau, J. C., Morais, J., Fox, K. A. A., Bohula, E. A., Murphy, S. A., Braunwald, E., Morrow, D. A. Tags: Lipids, Lipoproteins, and Cardiovascular Risk Factors Source Type: research